MedPath

Detection of Early Gastric Cancers Using Confocal Laser Endomicroscopy

Not Applicable
Completed
Conditions
Stomach Neoplasms
Precancerous Conditions
Interventions
Device: Endomicroscope (Pentax, Tokyo, Japan)
Device: Gastroscopes (Pentax, Tokyo, Japan)
Registration Number
NCT00851305
Lead Sponsor
Shandong University
Brief Summary

The purpose of this study is to determine whether endomicroscopy can improve the detection of Early Gastric Cancers (EGC).

Detailed Description

Endoscopy is proved to be the best method to achieve early diagnosis of gastric cancer (GC). Confocal laser endomicroscopy (CLE), a new diagnostic modality, has been shown to be valuable in increasing the diagnostic yield of colorectal neoplasias, but it is not clear whether CLE is helpful to find out early gastric cancer (EGC).The aim of the study is to investigate the value of CLE in improving the detection of EGCs.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
1786
Inclusion Criteria
  • 45 years old ≤ age < 80 years old
  • Patients with dyspeptic symptoms or with gastric premalignant conditions for surveillance gastroscopy
Exclusion Criteria
  • Known cancers or gastrectomy

  • Scheduled for endoscopic treatment

  • Alarm symptoms such as dysphagia, anaemia, gastrointestinal bleeding or obstruction, marked weight loss

  • Under conditions such as:

    • ascites
    • jaundice
    • liver cirrhosis
    • impaired renal function
    • coagulopathy
    • fever
    • pregnancy
    • breastfeeding
  • Inability to provide informed consent

  • Known allergy to fluorescein sodium

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
1 confocal laser endomicroscopyEndomicroscope (Pentax, Tokyo, Japan)Targeted biopsies are performed when the lesion was considered as IM, dysplasia or carcinoma by confocal laser endomicroscopy.
2 Conventional endoscopyGastroscopes (Pentax, Tokyo, Japan)Routine biopsies are performed when the lesion was considered as IM, dysplasia or carcinoma by conventional endoscopy.
Primary Outcome Measures
NameTimeMethod
To compare the rate of EGCs/GCs using CLE versus conventional gastroscopy.one year
Secondary Outcome Measures
NameTimeMethod
To evaluate the efficacy of in vivo CLE on different pathological characteristics of EGCs.one year

Trial Locations

Locations (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

🇨🇳

Jinan, Shandong, China

© Copyright 2025. All Rights Reserved by MedPath